Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Journal of Pharmaceutical Health Care and Sciences
|
July 10, 2026
Syndrome of inappropriate antidiuretic hormone secretion following immune effector cell-associated neurotoxicity syndrome during blinatumomab therapy: a case report
Misato Yoshihara, Satoshi Yuyama, Osamu Yasumuro, et al.
Journal of Pharmaceutical Health Care and Sciences
|
August 19, 2025
Impact of concomitant use of pazopanib and gastric acid suppressants on progression-free survival and safety in patients with sarcoma: a retrospective study
Tatsuya Isezaki, Hitomi Yuyama, Osamu Yasumuro, et al.
Journal of Clinical Pharmacology
|
April 6, 2022
Development of Risk Prediction Model for Grade 2 or Higher Hypocalcemia in Patients With Bone Metastasis Treated With Denosumab Plus Cholecalciferol (Vitamin D<sub>3</sub> )/Calcium Supplement
Keisuke Ikegami, Masayuki Hashiguchi, Hayato Kizaki, et al.
Biological & Pharmaceutical Bulletin
|
January 3, 2023
Investigation of Prescription Status and Exploration of Risk Factors Related to Denosumab-Induced Hypocalcemia in Combination Therapy with 1α,25-Dihydroxy-vitamin D<sub>3</sub>
Keisuke Ikegami, Megumi Saito, Shungo Imai, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
October 24, 2017
Changes in gefitinib, erlotinib and osimertinib pharmacokinetics under various gastric pH levels following oral administration of omeprazole and vonoprazan in rats
Osamu Yasumuro, Shinya Uchida, Yasuharu Kashiwagura, et al.
Journal of Pharmaceutical Health Care and Sciences
|
October 28, 2025
Assessing the utility and challenges for implementation of a risk prediction system: a usability study with hospital pharmacists
Keisuke Ikegami, Masami Tsuchiya, Hayato Kizaki, et al.
Biological & Pharmaceutical Bulletin
|
June 18, 2025
Validation of Risk Prediction System for Denosumab-Induced Hypocalcemia with an External Clinical Dataset
Keisuke Ikegami, Masami Tsuchiya, Shungo Imai, et al.
Studies in Health Technology and Informatics
|
August 8, 2025
Development of an Automated Classification System for Medication-Related Incident Factors: A Practical Approach to Enhancing Patient Safety Management
Yuri Takamatsu, Sayaka Ebara, Hayato Kizaki, et al.
JCO Clinical Cancer Informatics
|
July 15, 2024
External Validation and Update of the Risk Prediction Model for Denosumab-Induced Hypocalcemia Developed From a Hospital-Based Administrative Database
Keisuke Ikegami, Shungo Imai, Osamu Yasumuro, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Journal of Pharmaceutical Health Care and Sciences
|
July 10, 2026
Syndrome of inappropriate antidiuretic hormone secretion following immune effector cell-associated neurotoxicity syndrome during blinatumomab therapy: a case report
Misato Yoshihara, Satoshi Yuyama, Osamu Yasumuro, et al.
Journal of Pharmaceutical Health Care and Sciences
|
August 19, 2025
Impact of concomitant use of pazopanib and gastric acid suppressants on progression-free survival and safety in patients with sarcoma: a retrospective study
Tatsuya Isezaki, Hitomi Yuyama, Osamu Yasumuro, et al.
Journal of Clinical Pharmacology
|
April 6, 2022
Development of Risk Prediction Model for Grade 2 or Higher Hypocalcemia in Patients With Bone Metastasis Treated With Denosumab Plus Cholecalciferol (Vitamin D<sub>3</sub> )/Calcium Supplement
Keisuke Ikegami, Masayuki Hashiguchi, Hayato Kizaki, et al.
Biological & Pharmaceutical Bulletin
|
January 3, 2023
Investigation of Prescription Status and Exploration of Risk Factors Related to Denosumab-Induced Hypocalcemia in Combination Therapy with 1α,25-Dihydroxy-vitamin D<sub>3</sub>
Keisuke Ikegami, Megumi Saito, Shungo Imai, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
October 24, 2017
Changes in gefitinib, erlotinib and osimertinib pharmacokinetics under various gastric pH levels following oral administration of omeprazole and vonoprazan in rats
Osamu Yasumuro, Shinya Uchida, Yasuharu Kashiwagura, et al.
Journal of Pharmaceutical Health Care and Sciences
|
October 28, 2025
Assessing the utility and challenges for implementation of a risk prediction system: a usability study with hospital pharmacists
Keisuke Ikegami, Masami Tsuchiya, Hayato Kizaki, et al.
Biological & Pharmaceutical Bulletin
|
June 18, 2025
Validation of Risk Prediction System for Denosumab-Induced Hypocalcemia with an External Clinical Dataset
Keisuke Ikegami, Masami Tsuchiya, Shungo Imai, et al.
Studies in Health Technology and Informatics
|
August 8, 2025
Development of an Automated Classification System for Medication-Related Incident Factors: A Practical Approach to Enhancing Patient Safety Management
Yuri Takamatsu, Sayaka Ebara, Hayato Kizaki, et al.
JCO Clinical Cancer Informatics
|
July 15, 2024
External Validation and Update of the Risk Prediction Model for Denosumab-Induced Hypocalcemia Developed From a Hospital-Based Administrative Database
Keisuke Ikegami, Shungo Imai, Osamu Yasumuro, et al.
Page
of 1